In conclusion, we demonstrated that IRh improved IMQ-induced psoriasis-like dermatitis by decreasing TNF-α, IL-6, IL-17A, and nuclear NF-κB levels in the skin, and increasing malondialdehyde (MDA) levels in plasma. The gene discussed is IL17A; the disease is skin disorder.